Electronic common technical document
Electronic Common Technical Document (eCTD) is a standard format for the submission of regulatory information to drug regulatory authorities. The eCTD harmonizes the submission process for pharmaceuticals and is widely used by the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Japan Pharmaceuticals and Medical Devices Agency (PMDA), among others. It is designed to facilitate the creation, review, lifecycle management, and archival of electronic submissions.
Overview[edit | edit source]
The eCTD is an interface for the pharmaceutical industry to agency transfer of regulatory information while taking into consideration the need to protect intellectual property and personal data. It is based on the International Conference on Harmonisation (ICH) specifications. The eCTD is structured in a hierarchical format and is composed of five modules:
- Module 1: Regional Administrative Information (specific to each regulatory region)
- Module 2: Summaries (overview of the entire submission)
- Module 3: Quality (information on drug substance, drug product, and manufacturing)
- Module 4: Nonclinical Study Reports (toxicology reports)
- Module 5: Clinical Study Reports (results of clinical trials)
Benefits[edit | edit source]
The adoption of the eCTD format offers several benefits over paper-based submissions, including:
- Improved efficiency in the submission and review process
- Enhanced quality of submissions through standardization
- Easier lifecycle management of a drug application
- Reduced paper usage, contributing to environmental sustainability
Challenges[edit | edit source]
Transitioning to eCTD format can present challenges, such as:
- Initial investment in eCTD management software and training
- Compliance with varying regional requirements within Module 1
- Ensuring data integrity and security
Future Directions[edit | edit source]
The eCTD format continues to evolve, with updates focusing on enhancing usability, supporting new types of content, and improving integration with other regulatory information management systems. Future developments may include more advanced functionalities for lifecycle management and further harmonization of global submission standards.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD